Free Trial

Zacks Research Estimates MKS's Q2 Earnings (NASDAQ:MKSI)

MKS logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Zacks Research raised its outlook on MKS, estimating Q2 2026 earnings of $2.92 per share and projecting continued growth in later years, including $15.00 EPS in FY2027 and $18.24 EPS in FY2028.
  • MKS recently beat Wall Street expectations in its latest quarterly report, posting $2.30 EPS on $1.08 billion in revenue, both above estimates, and the company guided Q2 2026 EPS to $2.60-$3.20.
  • The stock has strong analyst support overall, with a Moderate Buy consensus and an average price target of $324.92, though some insider selling and a modest dividend of $0.25 per share were also noted.
  • Five stocks we like better than MKS.

MKS Inc. (NASDAQ:MKSI - Free Report) - Equities research analysts at Zacks Research issued their Q2 2026 earnings estimates for shares of MKS in a research report issued to clients and investors on Wednesday, May 27th. Zacks Research analyst Team forecasts that the scientific and technical instruments company will earn $2.92 per share for the quarter. The consensus estimate for MKS's current full-year earnings is $11.54 per share. Zacks Research also issued estimates for MKS's Q3 2026 earnings at $3.22 EPS, Q4 2026 earnings at $3.42 EPS, FY2026 earnings at $11.86 EPS, Q1 2027 earnings at $3.53 EPS, Q2 2027 earnings at $3.81 EPS, Q3 2027 earnings at $3.95 EPS, Q4 2027 earnings at $3.72 EPS, FY2027 earnings at $15.00 EPS, Q1 2028 earnings at $4.68 EPS and FY2028 earnings at $18.24 EPS.

MKS (NASDAQ:MKSI - Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.00 by $0.30. The firm had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. MKS had a net margin of 8.06% and a return on equity of 21.49%. The company's revenue for the quarter was up 15.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.71 EPS. MKS has set its Q2 2026 guidance at 2.600-3.200 EPS.

A number of other research firms also recently commented on MKSI. Mizuho set a $400.00 price objective on shares of MKS in a report on Wednesday. Wall Street Zen downgraded shares of MKS from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 23rd. JPMorgan Chase & Co. increased their price objective on shares of MKS from $305.00 to $365.00 and gave the company an "overweight" rating in a report on Friday, May 8th. Cantor Fitzgerald increased their price objective on shares of MKS from $300.00 to $400.00 and gave the company an "overweight" rating in a report on Wednesday, April 22nd. Finally, TD Cowen reiterated a "buy" rating on shares of MKS in a report on Thursday, May 7th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $324.92.

Get Our Latest Analysis on MKS

MKS Stock Down 1.4%

MKSI stock opened at $323.41 on Friday. The company has a market cap of $21.84 billion, a price-to-earnings ratio of 67.66, a PEG ratio of 1.19 and a beta of 1.98. The company has a current ratio of 1.11, a quick ratio of 0.70 and a debt-to-equity ratio of 0.94. MKS has a 12 month low of $80.22 and a 12 month high of $339.00. The firm has a 50-day moving average of $274.66 and a two-hundred day moving average of $223.75.

Hedge Funds Weigh In On MKS

Hedge funds have recently made changes to their positions in the stock. Blue Trust Inc. lifted its stake in shares of MKS by 1.1% during the first quarter. Blue Trust Inc. now owns 4,274 shares of the scientific and technical instruments company's stock valued at $982,000 after buying an additional 47 shares during the period. Covestor Ltd grew its holdings in MKS by 14.7% in the fourth quarter. Covestor Ltd now owns 390 shares of the scientific and technical instruments company's stock valued at $63,000 after purchasing an additional 50 shares during the period. Daiwa Securities Group Inc. grew its holdings in MKS by 10.4% in the fourth quarter. Daiwa Securities Group Inc. now owns 530 shares of the scientific and technical instruments company's stock valued at $85,000 after purchasing an additional 50 shares during the period. Quadrant Capital Group LLC raised its stake in MKS by 1.3% during the fourth quarter. Quadrant Capital Group LLC now owns 4,335 shares of the scientific and technical instruments company's stock worth $693,000 after purchasing an additional 55 shares during the period. Finally, MassMutual Private Wealth & Trust FSB raised its stake in MKS by 6.9% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 898 shares of the scientific and technical instruments company's stock worth $144,000 after purchasing an additional 58 shares during the period. Hedge funds and other institutional investors own 99.79% of the company's stock.

Insider Transactions at MKS

In related news, Director Gerald G. Colella sold 20,000 shares of the company's stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $333.40, for a total value of $6,668,000.00. Following the transaction, the director directly owned 20,017 shares in the company, valued at approximately $6,673,667.80. This represents a 49.98% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Eric Robert Taranto sold 4,568 shares of the company's stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $220.52, for a total value of $1,007,335.36. Following the completion of the transaction, the executive vice president owned 15,445 shares in the company, valued at $3,405,931.40. This represents a 22.83% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 56,723 shares of company stock valued at $17,830,688 in the last ninety days. 0.57% of the stock is currently owned by corporate insiders.

MKS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Wednesday, June 3rd will be issued a $0.25 dividend. The ex-dividend date is Wednesday, June 3rd. This represents a $1.00 dividend on an annualized basis and a yield of 0.3%. MKS's dividend payout ratio is currently 20.92%.

Key Headlines Impacting MKS

Here are the key news stories impacting MKS this week:

  • Positive Sentiment: Zacks Research raised its outlook across multiple future periods for MKS, with estimates pointing to solid earnings growth from $11.86 per share in FY2026 to $15.00 in FY2027 and $18.24 in FY2028, reinforcing the market’s growth narrative for the stock.
  • Positive Sentiment: The company’s latest quarterly report topped expectations, with MKS posting $2.30 EPS on $1.08 billion in revenue, both above estimates, and management guided Q2 2026 EPS to $2.60-$3.20, which supports investor confidence.
  • Neutral Sentiment: MKS recently announced a quarterly dividend of $0.25 per share, payable June 12, which is supportive but not large enough to be a major stock driver on its own.
  • Negative Sentiment: Several insiders, including EVP David Philip Henry and Director Joseph Donahue, sold shares this week under pre-arranged plans, which can create a modest headwind for sentiment even if the sales were not necessarily a bearish signal.

MKS Company Profile

(Get Free Report)

MKS Instruments, Inc NASDAQ: MKSI designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company's core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company's product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.

Featured Articles

Earnings History and Estimates for MKS (NASDAQ:MKSI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in MKS Right Now?

Before you consider MKS, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MKS wasn't on the list.

While MKS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines